Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R K Patel

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|June 1, 1990
Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetilM T Borin, G S Hughes, C R Spillers, et al.
QJM : Monthly Journal of the Association of Physicians|July 13, 2010
The use of an exclusion-based risk-assessment model for venous thrombosis improves uptake of appropriate thromboprophylaxis in hospitalized medical patientsC Bagot, S Gohil, R Perrott, et al.
Thrombosis Research|November 7, 2020
UK real-world experience of prescribing rivaroxaban for acute venous thromboembolism in obesity: Results from the FIRST RegistryV Speed, J P Patel, L N Roberts, et al.
Current Medical Research and Opinion|January 1, 1991
Lifestyle changes in mild asthma during intermittent symptom-related use of terbutaline inhaled via 'Turbohaler'M Northfield, R K Patel, A Richardson, et al.
Journal of Thrombosis and Haemostasis : JTH|December 7, 2011
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial: a rebuttalJ P Patel, B Green, R K Patel, et al.
Journal of Clinical Pharmacology|December 1, 1991
Pharmacokinetic and tolerance studies of cefpodoxime after single- and multiple-dose oral administration of cefpodoxime proxetilM T Borin, G S Hughes, R K Patel, et al.
Clinical and Experimental Immunology|March 30, 2010
Altered expression of signalling lymphocyte activation molecule (SLAM) family receptors CS1 (CD319) and 2B4 (CD244) in patients with systemic lupus erythematosusJ R Kim, S O Mathew, R K Patel, et al.
International Journal of Cancer|October 23, 1997
DNA repair proficiency in breast cancer patients and their first-degree relativesR K Patel, A H Trivedi, D C Arora, et al.
Neoplasma|January 1, 1994
Evaluation of chemopreventive effects of betel leaf on the genotoxicity of pan masalaA H Trivedi, R K Patel, U M Rawal, et al.
Carcinogenesis|September 1, 1994
Ethanol potentiates the clastogenicity of pan masala--an in vitro experienceR K Patel, A H Trivedi, R J Jaju, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|June 1, 1990
Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetilM T Borin, G S Hughes, C R Spillers, et al.
QJM : Monthly Journal of the Association of Physicians|July 13, 2010
The use of an exclusion-based risk-assessment model for venous thrombosis improves uptake of appropriate thromboprophylaxis in hospitalized medical patientsC Bagot, S Gohil, R Perrott, et al.
Thrombosis Research|November 7, 2020
UK real-world experience of prescribing rivaroxaban for acute venous thromboembolism in obesity: Results from the FIRST RegistryV Speed, J P Patel, L N Roberts, et al.
Current Medical Research and Opinion|January 1, 1991
Lifestyle changes in mild asthma during intermittent symptom-related use of terbutaline inhaled via 'Turbohaler'M Northfield, R K Patel, A Richardson, et al.
Journal of Thrombosis and Haemostasis : JTH|December 7, 2011
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial: a rebuttalJ P Patel, B Green, R K Patel, et al.
Journal of Clinical Pharmacology|December 1, 1991
Pharmacokinetic and tolerance studies of cefpodoxime after single- and multiple-dose oral administration of cefpodoxime proxetilM T Borin, G S Hughes, R K Patel, et al.
Clinical and Experimental Immunology|March 30, 2010
Altered expression of signalling lymphocyte activation molecule (SLAM) family receptors CS1 (CD319) and 2B4 (CD244) in patients with systemic lupus erythematosusJ R Kim, S O Mathew, R K Patel, et al.
International Journal of Cancer|October 23, 1997
DNA repair proficiency in breast cancer patients and their first-degree relativesR K Patel, A H Trivedi, D C Arora, et al.
Neoplasma|January 1, 1994
Evaluation of chemopreventive effects of betel leaf on the genotoxicity of pan masalaA H Trivedi, R K Patel, U M Rawal, et al.
Carcinogenesis|September 1, 1994
Ethanol potentiates the clastogenicity of pan masala--an in vitro experienceR K Patel, A H Trivedi, R J Jaju, et al.
Pageof 9